Overview
Sirisha Jain, MD, is a board-certified hematologist/oncologist with Harrison HealthPartners. Dr. Jain's goal is to, in this time of rapid growth of oncology treatments, with new research being published weekly, incorporate the latest treatments into her practice and stay current on the research. She hopes to form a partnership with her patients where she can help them navigate the information and difficult choices a cancer diagnosis brings. Dr. Jain believes it is vital for the health of her patients to focus on treating the whole person and not just the cancer diagnosis.
Dr. Jain is highly rated in 78 conditions, according to our data. Her top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1900 Northwest Myhre Road, Silverdale, WA 98383
Seattle Children's Hospital
Douglas Hawkins is a Hematologist and an Oncologist in Seattle, Washington. Dr. Hawkins is highly rated in 16 conditions, according to our data. His top areas of expertise are Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Osteosarcoma, Osteotomy, and Bone Marrow Aspiration.
Gme Office University Of Washington
Hans-peter Kiem is a Hematologist and an Oncologist in Seattle, Washington. Dr. Kiem is highly rated in 17 conditions, according to our data. His top areas of expertise are X-Linked Severe Combined Immunodeficiency, Congenital Aplastic Anemia, Fanconi Anemia, Severe Combined Immunodeficiency (SCID), and Bone Marrow Transplant.
Seattle Children's Hospital
Mignon Loh is a Hematologist and an Oncologist in Seattle, Washington. Dr. Loh is highly rated in 7 conditions, according to our data. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Juvenile Myelomonocytic Leukemia (JMML), Leukemia, Splenectomy, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Sirisha M. Jain
How do I make an appointment with Dr. Sirisha M. Jain?
You can book an appointment with Dr. Sirisha M. Jain by calling their office at 564-240-3100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sirisha M. Jain a top-rated expert for Angiosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sirisha M. Jain is classified as an Distinguished expert for Angiosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sirisha M. Jain specialize in?
While Dr. Sirisha M. Jain is a Oncology, they have specific expertise in Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Sirisha M. Jain accept my insurance?
Dr. Sirisha M. Jain accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 564-240-3100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Jain isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Jain isDistinguished. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Jain isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- Colorectal CancerDr. Jain isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Jain isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Jain isDistinguished. Learn about Familial Pancreatic Cancer.
- Advanced
- Adult Immune ThrombocytopeniaDr. Jain isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Jain isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Jain isAdvanced. Learn about Anemia.
- Angioimmunoblastic T-cell Lymphoma
- Aplastic AnemiaDr. Jain isAdvanced. Learn about Aplastic Anemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Jain isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Jain isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Jain isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Jain isExperienced. Learn about Acute Promyelocytic Leukemia.